Mandya DC instructs officials to ensure avilability of anti-venom, anti-rabies injections at health centres
Deputy Commissioner on Tuesday instructed health officials to ensure adequate stock of anti-venom and anti-rabies injections and related medicines at all Primary Health Centres (PHCs) and Community Health Centres (CHCs) in the district.
Chairing a meeting of officials in Mandya on Tuesday, Mr. Kumar said the heads of the PHCs and CHCs should ensure availability of the medicine in their respective centres.
He recalled the incident that took place in Mandya recently in which a girl, who suffered a dog bite in her native in Maddur taluk, died in a road accident when she was being taken to Mandya Institute of Medical Sciences (MIMS) for an anti-rabies injection. It could have been averted had the girl been provided timely medical help in her native, he said.
Mr. Kumar said emergency medicines should be stocked at the health centres. He appointed taluk health officers as nodal officers to monitor the same.
Mr. Kumar told the officials to make use of technology since they can access information on medical stock on their mobile phones.
With the onset of monsoon, the Deputy Commissioner said there is a likelihood of increased incidence of infectious diseases such as dengue, malaria, and chikungunya. He instructed the officials to conduct awareness programmes more frequently at construction sites where there was a high chance of water stagnation.
A person has been tested positive for COVID-19 in Mandya district. Severe Acute Respiratory Infection cases reported at MIMS were subjected to testing, he said.
Screenings for Non Communicable Diseases (NCD) like diabetes, hypertension, and cancer were being conducted, Mr. Kumar said, adding that awareness programmes were necessary in areas where there were a large number of such patients.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
an hour ago
- India.com
Covid-19 pandemic, World War 2, 9/11 attacks...: Who was Baba Vanga, Bulgarian seer whose chilling prophecies have raised doomsday fears?
Baba Vanga (File) Baba Vanga latest predictions: Baba Vanga, the famous 20th century blind prophet of Bulgaria, had 'accurately' predicted major world events that took reshaped the global order in last few decades, including the September 11 terror attack on New York's Twin Towers, the outcome of World War 2, and even the recent Covid-19 pandemic that killed millions across the world. But who exactly was Baba Vanga, and how did she purportedly gain the mysterious gift of prophecy and foresight? Let us find delve into the life and times of this mysterious woman, whose future prophecies have triggered fears of a coming doomsday among many 'believers'. Who was Baba Vanga? Born in in Strumica in the Salonica vilayet, then part of the Ottoman Empire, on October 3, 1911, Vangeliya Pandeva Gushterova, later known as Baba Vanga, or 'Grandmother Vanga', lost her eyesight at the tender age of 12. However, after losing her sight, Vangeliya, aka Baba Vanga, allegedly gained the gift of clairvoyance and precognition, which purportedly enabled her to view future events with clarity and precision. Baba Vanga, famously known as the 'Nostradamus of the Balkans', spent most of her life in the Rupite area in the Belasica mountains in Bulgaria, and shot to fame in the late 1970s and 1980s, when she became widely known in Eastern Europe for her alleged clairvoyance abilities. Regarded as one of the most famous mystics of the 2oth century, Baba Vanga died in 1996, but has left behind a trove of prophecies for the future that continue to captivate and send chills down the spine of billions across the world. Baba Vanga prophecies that came 'true' Baba Vanga made prophecies for over 50 years during her lifetime. It is believed that the Bulgarian seer made a total of 5079 predictions until her death on August 11, 1996. Believers claims that Baba Vanga had accurately predicted the outcome of World War II, and also the collapse of Soviet Union, which happened in 1991. She's also believed to have predicted the 9/11 attack on the Twin Towers in New York, the shocking death of Princess Diana, 2004 Indian Ocean tsunami, and even the Covid-19 pandemic.
Hans India
2 hours ago
- Hans India
Union Secretary reviews UMEED portal's implementation in Maharashtra
Ahead of the roll out of rules for the Waqf portal, Union Minority Affairs Secretary Chandra Shekhar Kumar held a review meeting with Maharashtra officials for smooth uploading of details related to properties on UMEED, an official said on Sunday. Unified Waqf Management, Empowerment, Efficiency and Development Act, 1995 (UMEED) Central Portal, launched on June 6, needs the rules to support the statutory requirements. During the meeting on Saturday, the Secretary encouraged proactive participation and invited suggestions from state authorities to streamline the implementation process. As per the mandate of the UMEED Portal, details of all registered Waqf properties across India are to be mandatorily uploaded within six months. Those present in the meeting, chaired by the Union Secretary, included the state secretary, senior officials, and the CEO of the Maharashtra State Waqf Board. This was the Union Secretary's second such visit following a similar review in Bihar last week. Secretary Chandra Shekhar Kumar encouraged proactive participation and invited suggestions from state authorities to streamline the implementation process, said an official statement. The CEO of the Waqf Board requested the Centre to revisit and ease certain leasing provisions related to Waqf properties. The Union Secretary assured that the request will be examined sympathetically, reaffirming the Centre's commitment to empowering Waqf Boards and enhancing Waqf property management. Apart from reviewing UMEED implementation, the Secretary also assessed the status of projects under the Pradhan Mantri Jan Vikas Karyakram (PMJVK) in Maharashtra. He directed the state officials to submit all pending proposals to the Ministry within one week for necessary action. Kumar also held a meeting with officials of the Haj Committee of India (HCoI) in Mumbai, congratulating them on the smooth and successful conduct of Haj 2025. He expressed satisfaction that this year recorded the lowest number of deaths and health-related incidents among Indian Haj pilgrims. He attributed this achievement to improved coordination between the Ministry, the Haj Committee of India, deputationists, Saudi Arabian authorities, and local support systems. The Secretary specially acknowledged the effectiveness of the Haj Suvidha App, which played a crucial role in enhancing the pilgrim experience and easing on-ground challenges. He said that insights from this year's Haj operations will be used to further improve arrangements for Haj 2026.
Time of India
2 hours ago
- Time of India
A new HIV drug promises 99.9% protection. But it's making Indian health activists wary; Why?
The US Food and Drug Administration (FDA) has approved lenacapavir, a new injectable drug that claims to offer 99.9% protection against HIV. But concerns are being raised in India over its affordability and accessibility, particularly through the public healthcare system. The injection costs around ₹24 lakh ($28,218) for two doses administered six months apart. Lenacapavir belongs to the class of HIV prevention drugs known as pre-exposure prophylaxis (PrEP). However, India's National AIDS Control Organisation (NACO) has not included PrEP in its public programmes so far. "Our govt distributes condoms to break HIV transmission, it provides antiretroviral therapy drugs to prevent parent-to-child transmission of HIV, but it hasn't ever given PrEP to youngsters who are likely to indulge in high-risk behaviour," said health activist Ganesh Acharya. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Hanoi: Unsold Furniture Liquidation 2024 (Prices May Surprise You) Unsold Furniture | Search Ads Learn More Undo He added that NACO had made it mandatory for its counselling centres to provide information on PrEP a couple of years ago. He also expressed concern that 75% of the 88% people diagnosed with HIV in Mumbai in 2023–24 were from the 15–49 age group. PrEP, however, remains available only in the private sector. Experts call for government action, tiered pricing PrEP has existed for over a decade and is widely used in developed countries. In India, public health discussions around PrEP only began recently. Live Events A doctor from a government hospital said, "They set up a committee, then a white paper was brought out that served as a backgrounder for guidelines that were drawn up last year. However, there has been no development since." Dr Ishwar Gilada of the People's Health Organisation (India) said, "The govt should distribute PrEP to check the spread of the disease, which has only been increasing in recent years. The total number of HIV-positive people in India increased from 2.2 million to 2.5 million in a few years." According to him, sexually transmitted infections have been rising in Mumbai. "A recent survey in Mumbai among men who have sex with men found that 60% of them were positive for the human papilloma virus. While gonorrhoea and chlamydia vanished 25 years ago, their numbers are shooting up," he said. He suggested a three-tier pricing structure: full price for those who can afford it, subsidised pricing for some, and free access for those unable to pay. NACO officials were not available for comment. India has also not approved HIV self-testing kits. "We have self-testing kits for pregnancy, diabetes, and Covid, but policymakers fear about the mental health of people after a positive result in self-testing HIV kits," said Dr Gilada. A senior doctor suggested that similar fears may be behind the delay in rolling out PrEP publicly, as officials worry it might encourage risky behaviour. Hope for lower-cost versions as UNAIDS urges price drop Bala from Bombay Gay called lenacapavir a "monumental milestone forward in HIV treatment and prevention," but added that the current price point makes it inaccessible in India. "So, we have to wait and see if prices will come down over time," he said. Dr Gilada expressed hope that Indian manufacturers licensed by Gilead Sciences might eventually offer the injection at less than $100 per year. "India can do it," he said. UNAIDS, in a recent statement, urged Gilead Lifesciences to reduce the price of the new drug to improve global access.
